-
Nektar Therapeutics (NKTR $24.48)
- $24.48 Cap: $330M
- View NKTR Profile
- View Questions on NKTR
Detailed Quote
Questions on this company?
Become a Member
Company Profile
{tplLang.businessdescription | toLang tLang}
{ profileData.description }
{tplLang.details | toLang tLang}
{tplLang.ceo | toLang tLang}
{profileData.profile.details.ceo}
{tplLang.employees | toLang tLang}
{profileData.profile.details.employees | numeraljs '0,0'}
{tplLang.issuetype | toLang tLang}
{profileData.profile.details.issuetype | asIssueType}
{tplLang.industryclassifications | toLang tLang}
{tplLang.sector | toLang tLang}
{profileData.profile.classification.sector}
{tplLang.industry | toLang tLang}
{profileData.profile.classification.industry}
{tplLang.toolname| toLang tLang}
There is no {tplLang.toolname| toLang tLang} currently available for
{data.symbolstring}.
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
-
Biogen Inc. (BIIB $127.85)
- $127.85 P/E (TTM): 12.12X Cap: $18.73B
- View BIIB Profile
- View Questions on BIIB
-
FLIR Systems Inc. (FLIR $57.34)
- $57.34 P/E (TTM): 33.53X Cap: $7.56B
- View FLIR Profile
- View Questions on FLIR
-
Cognex Corporation (CGNX $34.26)
- $34.26 P/E (TTM): 49.6X Cap: $5.75B
- View CGNX Profile
- View Questions on CGNX
-
Arista Networks Inc. (ANET $109.78)
- $109.78 P/E (TTM): 47.09X Cap: $137.87B
- View ANET Profile
- View Questions on ANET
-
Nektar Therapeutics (NKTR $24.48)
- $24.48 Cap: $330M
- View NKTR Profile
- View Questions on NKTR
-
Rapid7 Inc. (RPD $22.79)
- $22.79 P/E (TTM): 56.68X Cap: $1.45B
- View RPD Profile
- View Questions on RPD
Q: I hold the above and they all had favorable comments from 5i on growth at one point. Is growth still intact? Do you see anything that's changed in the companies or the environment that would affect any of these? They are inside an RSP for long term growth. TIA!
-
Nektar Therapeutics (NKTR $24.48)
- $24.48 Cap: $330M
- View NKTR Profile
- View Questions on NKTR
Q: Hi Peter and Ryan,
What is your outlook on Nektar Therapeutic?
Would you be a buyer after it's experiment of cancer drug disappointment.
Thank you for your help as always.
What is your outlook on Nektar Therapeutic?
Would you be a buyer after it's experiment of cancer drug disappointment.
Thank you for your help as always.
-
Garmin Ltd. (Switzerland) (GRMN $227.71)
- $227.71 P/E (TTM): 29.8X Cap: $43.84B
- View GRMN Profile
- View Questions on GRMN
-
Ebix Inc. (EBIX)
- P/E (TTM): 7.25X Cap: $35M
- View EBIX Profile
- View Questions on EBIX
-
Exact Sciences Corporation (EXAS $49.83)
- $49.83 Cap: $9.12B
- View EXAS Profile
- View Questions on EXAS
-
Collectors Universe Inc. (CLCT $91.92)
- $91.92 P/E (TTM): 47.28X Cap: $852M
- View CLCT Profile
- View Questions on CLCT
-
Issuer Direct Corporation (ISDR)
- Cap: $36M
- View ISDR Profile
- View Questions on ISDR
-
Ichor Holdings (ICHR $21.67)
- $21.67 Cap: $739M
- View ICHR Profile
- View Questions on ICHR
-
Just Eat Takeaway.com N.V. (GRUB)
- P/E (TTM): -4.7X Cap: $7.22B
- View GRUB Profile
- View Questions on GRUB
-
Nektar Therapeutics (NKTR $24.48)
- $24.48 Cap: $330M
- View NKTR Profile
- View Questions on NKTR
-
Rapid7 Inc. (RPD $22.79)
- $22.79 P/E (TTM): 56.68X Cap: $1.45B
- View RPD Profile
- View Questions on RPD
Q: Can you recommend 8-10 small -mid cap USA stocks with high growth potential, good to excellent balance sheets that your team at 5i would own or do own and consider a long term buy. Can be from any sectors. Please exclude the following names, as these are currently already owned: BOX, FLIR, ANET, TEAM, GRUB, LLL, CGNX, ALGN
Insiders
Share Information
SEC Filings
News and Media